Schedule 13G ownership disclosure

CB Pharma Acquisition Corp.

Security class unavailable · CUSIP: G2029P126

Event date: 2014-12-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
300,000
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-16-007336
Form type
SC 13G
Filer
Origo Acquisition Corp
CIK
CIK 1619551
Filed
Jun 10, 2016
Reporting period
Dec 12, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub